| Drug Name |
Arformoterol tartrate |
| Drug ID |
BADD_D00160 |
| Description |
Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma. |
| Indications and Usage |
A bronchodilator used for the long term, symptomatic treatment of reversible bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
R03AC13; R03CC15 |
| DrugBank ID |
DB01274
|
| KEGG ID |
D01373
|
| MeSH ID |
D000068759
|
| PubChem ID |
9827062
|
| TTD Drug ID |
D0D1DI
|
| NDC Product Code |
64567-0022; 53104-7731; 63402-911; 70748-257; 66039-909; 50384-4279; 68462-833; 69097-168; 14501-0077; 0093-5955 |
| Synonyms |
Formoterol Fumarate | Formoterol Fumarate, ((R*,R*)-(+-))-isomer | 3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate | BD 40A | Formoterol | Eformoterol | Oxis | Arformoterol | Formoterol, ((R*,R*)-(+-))-isomer | Foradil |
